Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 5:40 PM ET

Health Care Technology

Company Overview of MedAvante, Inc.

Company Overview

MedAvante, Inc. provides technology-enabled signal detection solutions in clinical trials of treatments for central nervous system disorders worldwide. Its solutions include Virgil Investigative Study Platform for site-based assessments; and MedAvante Central Ratings for live assessments by remote central clinicians. The company also provides scientific risk reduction services, such as rater qualification and training; central review, a monitoring service in which calibrated clinicians review selected assessments that were administered by site raters; and remote ratings, a customized solution that offers sponsors protection against bias and variability. MedAvante, Inc. was formerly known as ...

100 American Metro Boulevard

Suite 106

Hamilton, NJ 08619

United States

Founded in 2002





Key Executives for MedAvante, Inc.

Co-Founder and Chief Executive Officer
Age: 51
Co-Founder and President
Chief Financial Officer
Senior Vice President of Global Operations and Information Technology
Age: 82
Senior Vice President of Global Science
Compensation as of Fiscal Year 2015.

MedAvante, Inc. Key Developments

MedaVante, Inc. Appoints Nigel Brown as Senior Advisor

MedAvante, Inc. announced that Dr. Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance Inc., will serve as a senior advisor to the company. Dr. Brown will counsel MedAvante on continuing its progress in electronic clinical outcome assessment (eCOA) solutions that improve data quality in CNS studies, enhance the ability to detect a clinical signal and reduce burden for investigative sites. He is CEO of Princeton Healthcare Advisory LLC and recently completed a decade of service as a member of the Executive Committee at Covance, now a division of LabCorp Holdings. In that role Brown was responsible for M&A, licensing and strategic partnership deals, including a groundbreaking $2.2 Billion 10-year strategic alliance broadly regarded as the large and most creative partnership deal in the history of the contract research organization (CRO) sector. In his advisory capacity, Brown will work closely with MedAvante's senior leadership team.

MedAvante, Inc. Appoints Thomas Weir as Senior Vice President of Global Operations and Information Technology

MedAvante, Inc. announced the appointment of Thomas Weir, Jr. to a new position as Senior Vice President of Global Operations and Information Technology. Weir brings more than 28 years of senior level leadership experience as a technical and operations executive heading up global multi-discipline engineering teams delivering software-based or highly engineered products. Over his career, he has provided direction for product design and development as well as engineering process, technical services and supply chain support. Weir began his career at the Boeing Company in software and systems engineering for both defense and commercial platforms. As Senior Vice President of Technology at Sensitech Inc., he was responsible for operations and engineering for multi-facility divisions in US, China, Europe and South America. Prior to joining MedAvante, Weir served as Vice President of Global Engineering at MEI, where he led a globally distributed, multi-discipline engineering team.

MedAvante, Inc. Releases New Software for the Virgil Investigative Study Platform

MedAvante, Inc. has released a major software upgrade to the groundbreaking Virgil Investigative Study Platform launched over a year ago. Virgil is now being used in large clinical trials covering various therapeutic indications with trial sites across the Americas, Eastern and Western Europe and the Asia Pacific region. Full Electronic Clinical Outcome Assessments (eCOA): With the latest software release, clinical trial sponsors can deploy all rating scale forms to the Virgil tablet to capture a holistic view of any subject's condition at any time during a study. Patient-reported (PRO) and observer-reported (ObsRO) outcomes are now collected in the Virgil tablet and seamlessly aligned in the Virgil web portal with the same intuitively interactive interface MedAvante developed to simplify and guide ClinRO rating instruments. Unobtrusive Video Recording: Virgil now adds easy-to-use video recording to the existing audio recording function, allowing users to view what the camera sees in a corner of the tablet screen next to the start, pause and stop controls. All recordings – video or audio – are automatically uploaded on submission by the rater and available for review in the secure, user-friendly Virgil web portal by permissioned users. Additional Flexibility: Other enhancements in response to user suggestions include the ability to easily activate or deactivate PROs assigned to subjects, based for example on declining cognitive status, an important need in AD prevention trials. Study coordinators can also change observers during the course of a study. Assigning and preparing for assessments has been simplified for clinicians, and new options have been added for tracking subjects and visits and viewing completed assessment scores, forms and recordings. Growing Library of Digital Rating Scales: The Virgil platform combines digital technology with clinical guidance to standardize COA ratings and ties together previously disconnected procedures and systems to minimize site burden, reduce 'noise' in study data and improve signal detection. Virgil is based on proprietary electronic source data technology used in tablet devices by MedAvante clinicians to administer more than 175,000 assessments in large global studies, capturing digital source data that has been accepted by both the FDA and the EMA in successful regulatory submissions. Virgil tablets standardize COA administration and scoring with real-time clinical guidance and built-in quality checks to flag errors and prevent missing data. Virgil makes administration easier and scoring of sensitive data points more consistent and accurate with a growing library of digital implementations of the most widely-used rating scale instruments, including PANSS, RBANS, MADRS, HAM-D, CDR, ADAS-Cog and many others. Robust operational capabilities built into the Virgil tablet and the web portal optimize quality and efficiency, sparing sites the onerous tasks of creating, handling and storing paperwork while reducing the requirements of on-site monitoring. Virgil's highly secure web portal removes any need to find and send paper documents in responding to queries.

Similar Private Companies By Industry

Company Name Region
ultraBridge, Inc. United States
PatientTrak United States
HybridChart Inc. United States
Canary Health Inc. United States
Advantage Management Solutions, Inc. United States

Recent Private Companies Transactions

Private Placement
July 22, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MedAvante, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at